Abstract The design, synthesis, crystal structure and interaction with DNA of the N,N'-(butane-1,4-diyl)bis(guanidinium) tetrachloroplatinate(ll) are described. Crystal data a 8.152(1 ), b 8.889(4), The structure was refined to R 0.039 and Rw 0.046 from 1853 reflections (I > 3(I)). This compound, named PtC4Gua, does not exhibit a center of symmetry and the center linker chain C(2) C(3) C(4) C (5) 
Introduction
Platinum complexes, like cis-diamminedichloroplatinum (11) (cisplatin) and carboplatin, are effective antitumor agents used for the treatment of genitourinary and head and neck cancers [1] . Very recently, oxaliplatin (1R,2R-diaminocyclohexanedicarboxylatoplatinum(ll)) has been recommended in metastatic colon rectal cancer treatment with neither nephrotoxicity nor cross-resistance to cisplatin [2] . The biological effects are attributed to the formation of adducts with DNA. Cisplatininduced bifunctional intrastrand cross-links between neighbouring purine base residues induce marked conformational kinks in DNA. These lesions are considered relatively difficult to repair [3] .
The severe side effects of cisplatin and the development of resistance have encouraged the design of alternative platinum compounds with a broader spectrum of activity, in particular against cisplatin-resistant cell lines. Over the last ten years, a large number of drugs containing the basic cis-[PtX2(amine)2] motif were synthesized [3] . Dimers formed by linking the monofunctional platinum species [Pt(dien)CI] + by a tetramethylene linker exhibit a greatly enhanced ability for interstrand cross-linking compared to cisplatin itself [4] . The bis(platinum) complex shown in Figure  represents a promising antitumor agent with a pronounced cytotoxic effect toward cell lines resistant to cisplatin [5] . Recently, a novel bifunctional triplatinum(ll) complex, BBR 3464, was shown to exhibit comparable or superior efficacity to cisplatin and is now entering phase clinical trials [6] . Its structure can be described as two trans [PtCI(NH)] units linked by a central NH(CH)eNH-trans Pt(NHa) NH(CH)eNH_ diamine chain.
Several non-classical platinum complexes that do not contain the aforementioned basic motif have also been developed. Among them, the compound [rhodamine-123] PtCI4 was the first tetrachloroplatinate (11) endowed with potent anticancer activity [7] . In addition, an (ethidium) PtCI4 conjugate showed reduced toxicity to mice compared to ethidium but equal trypanocidal activity [8] . These considerations prompted us to synthesize the bis(guanidinium) tetrachloroplatinate(ll) salt, hereafter named PtC4Gua, which incorporates a (butane-1,4-diyl)bis(guanidinium) cation 
This cation does not exhibit an inversion center half away along the C(2)-C(3) bond and the central linker chain C(1 C(2) C(3) C(4) exhibits a gauche conformation, as shown by the torsion angle value of -64.14. In contrast, in the crystal structure of S,S'-(1,8-octanediyl)bis(thiouronium)-tetrachloroplatinate(ll), the cation exhibits a centre of symmetry and packs in a mixed trans(t) and gauche(g) conformation, with a tgtttttgt sequence [9] . However, in the S,S'-(1,4- Figure 2 Perspective view of PtC4Gua generated by CAMERON using 50% probability ellipsoids for the non-hydrogen atoms. The crystallographic labelling scheme is shown. The hydrogen bonds are shown by dotted lines. SynTnetycode i" x, l+y, z ii -x, l-y, 1-z ;iii" 1-x,-1-y, -z ;iv" l+x,-l+y, z. The refined cell constants and other relevant crystal data are presented in Table 4 , together with details of the intensity measurements. The crystal was mounted, using glass fibers, on an ENRAF-NONIUS CAD4 diffractometer equipped with a graphite monochromator. The lattice parameters were refined using 25 reflections. The data were collected using the o-2e scan technique and with Mo K(z radiation 0.71073 ). During the data collection, three intensity control reflections were monitored every two hours, showing no loss of intensity. The data were corrected for Lorentz and polarisation effects. The structure was solved by a combination of direct methods using SIR procedure [13] Table 3 . Criteria for a satisfactory complete analysis were ratios of rms shift to standard deviation less than 0.1 and no significant features in final difference maps. Details of data collection and refinement are given in Table 4 . Calculations were performed with a PC CRYSTALS package program. The drawings of the molecules were generated using CAMERON [16] 
